PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
undecafluorohexanoic acid and its ammonium salt
show/hide
|
- | - | - | - | - | - | - | - | 1 | - | - | Details |
|
undecafluorohexanoic acid and its inorganic salts
show/hide
|
- | - | - | - | - | - | - | 1 | - | - | - | Details |
|
Zirconia Aluminosilicate Refractory Ceramic Fibres
are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium, silicon and zirconium are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm). c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight
show/hide
|
- | - | - | - | - | - | - | - | 1 | 1 | - | Details |
| ≥ 76.9% 3-[(1RS,3RS)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin and ≤ 23.1% 3-[(1RS,3SR)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin | - | - | - | - | - | - | - | 1 | - | - | - | Details |
| Formaldehyde | 200-001-8 | 50-00-0 | 1 | - | 1 | - | 1 | 2 | - | - | - | Details |
| Guanidinium chloride | 200-002-3 | 50-01-1 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Lactic acid | 200-018-0 | 50-21-5 | - | - | 3 | - | - | - | - | - | - | Details |
| Clofenotane | 200-024-3 | 50-29-3 | - | - | - | - | - | - | - | - | - | Details |
| Benzo[def]chrysene | 200-028-5 | 50-32-8 | - | - | - | - | - | - | 2 | - | - | Details |
| Amitriptyline | 200-041-6 | 50-48-6 | - | - | - | - | 1 | - | - | - | - | Details |
| O-acetylsalicylic acid | 200-064-1 | 50-78-2 | - | - | 1 | - | 1 | - | - | - | - | Details |
| 2-hydroxy-p-toluic acid | 200-068-3 | 50-85-1 | - | - | 1 | - | 1 | - | - | - | - | Details |
| 2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether | 200-076-7 | 51-03-6 | 1 | - | 2 | - | - | 1 | - | - | - | Details |
| 2,4-dinitrophenol | 200-087-7 | 51-28-5 | - | - | - | - | - | 1 | - | - | - | Details |
| Dexamphetamine | 200-112-1 | 51-64-9 | - | - | - | - | 1 | - | - | - | - | Details |
| Bronopol | 200-143-0 | 52-51-7 | - | - | - | 1 | - | 1 | - | - | - | Details |
| Cysteine hydrochloride | 200-157-7 | 52-89-1 | - | - | 3 | - | - | - | - | - | - | Details |
| Nicotine | 200-193-3 | 54-11-5 | - | - | - | - | - | 1 | - | - | - | Details |
| Sodium salicylate | 200-198-0 | 54-21-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Bis(4-hydroxy-N-methylanilinium) sulphate | 200-237-1 | 55-55-0 | 1 | - | - | - | - | - | - | - | - | Details |
| Chlorhexidine | 200-238-7 | 55-56-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Glycerol trinitrate | 200-240-8 | 55-63-0 | - | - | 2 | - | 1 | - | - | - | - | Details |
| 3,3'-iminodi(propylamine) | 200-261-2 | 56-18-8 | - | - | 1 | - | - | - | - | - | - | Details |
| Carbon tetrachloride | 200-262-8 | 56-23-5 | 1 | - | 2 | - | - | - | - | - | - | Details |
| Bis(tributyltin) oxide | 200-268-0 | 56-35-9 | - | - | - | - | - | - | 1 | - | - | Details |
| Benz[a]anthracene | 200-280-6 | 56-55-3 | - | - | - | - | 1 | - | 1 | - | - | Details |
| Glycerol | 200-289-5 | 56-81-5 | - | - | 1 | - | - | - | - | - | - | Details |
| Benzyltrimethylammonium chloride | 200-300-3 | 56-93-9 | - | - | 1 | - | - | - | - | - | - | Details |
| Chlorhexidine di(acetate) | 200-302-4 | 56-95-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Cetrimonium bromide | 200-311-3 | 57-09-0 | - | - | 1 | - | - | - | - | - | - | Details |
| Palmitic acid | 200-312-9 | 57-10-3 | - | - | 1 | - | - | - | - | - | - | Details |
| Urea | 200-315-5 | 57-13-6 | - | - | 2 | - | - | - | - | - | - | Details |
| Propane-1,2-diol | 200-338-0 | 57-55-6 | - | - | 1 | - | 1 | 1 | - | - | - | Details |
| Chlordane , pur | 200-349-0 | 57-74-9 | - | - | - | - | - | - | - | - | - | Details |
| Caffeine | 200-362-1 | 58-08-2 | - | - | - | - | 1 | - | - | - | - | Details |
| Theophylline | 200-385-7 | 58-55-9 | - | - | - | - | 1 | 1 | - | - | - | Details |
| Chlorocresol | 200-431-6 | 59-50-7 | - | - | - | - | - | 1 | - | - | - | Details |
| Edetic acid | 200-449-4 | 60-00-4 | - | - | 1 | - | 1 | - | - | - | - | Details |
| 4-aminoazobenzene | 200-453-6 | 60-09-3 | - | - | - | - | - | - | 1 | - | - | Details |
| 2-phenylethanol | 200-456-2 | 60-12-8 | - | - | 2 | - | 1 | - | - | - | - | Details |
| 2-mercaptoethanol | 200-464-6 | 60-24-2 | - | - | 2 | - | - | - | - | - | - | Details |
| Diethyl ether | 200-467-2 | 60-29-7 | 1 | - | 4 | - | - | - | - | - | - | Details |
| Methylhydrazine | 200-471-4 | 60-34-4 | - | - | - | - | - | 1 | - | - | - | Details |
| Acetamide | 200-473-5 | 60-35-5 | - | - | - | - | 1 | - | - | - | - | Details |
| Dieldrin | 200-484-5 | 60-57-1 | - | - | - | - | - | - | - | - | - | Details |
| Amitrole | 200-521-5 | 61-82-5 | - | - | 1 | - | - | - | - | - | - | Details |
| 4-nitrobenzoic acid | 200-526-2 | 62-23-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Sodium calcium edetate | 200-529-9 | 62-33-9 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Aniline | 200-539-3 | 62-53-3 | - | - | 1 | - | 2 | - | - | - | - | Details |
| thiourea; thiocarbamide | 200-543-5 | 62-56-6 | - | - | 1 | - | 1 | 1 | - | - | - | Details |